Page last updated: 2024-08-17

medroxyprogesterone acetate and Gall Bladder Diseases

medroxyprogesterone acetate has been researched along with Gall Bladder Diseases in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Anderson, GL; Aragaki, AK; Banack, H; Chlebowski, RT; Gass, M; Manson, JE; Prentice, RL; Qi, L; Rossouw, JE; Shadyab, AH; Snively, BM; Wallace, R; Zhao, S1
Cirillo, DJ; Greenland, P; LaCroix, AZ; Larson, JC; Limacher, MC; Rodabough, RJ; Wallace, RB1
Emory, LE; Meyer, WJ; Smith, ER; Walker, PA1

Trials

1 trial(s) available for medroxyprogesterone acetate and Gall Bladder Diseases

ArticleYear
Effect of estrogen therapy on gallbladder disease.
    JAMA, 2005, Jan-19, Volume: 293, Issue:3

    Topics: Aged; Cholecystectomy; Cholecystitis; Cholelithiasis; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Gallbladder Diseases; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Proportional Hazards Models; Risk Factors

2005

Other Studies

3 other study(ies) available for medroxyprogesterone acetate and Gall Bladder Diseases

ArticleYear
Dual-Outcome Intention-to-Treat Analyses in the Women's Health Initiative Randomized Controlled Hormone Therapy Trials.
    American journal of epidemiology, 2020, 09-01, Volume: 189, Issue:9

    Topics: Aged; Cardiovascular Diseases; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fractures, Bone; Gallbladder Diseases; Humans; Incidence; Intention to Treat Analysis; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Randomized Controlled Trials as Topic; Risk Factors; United States

2020
Postmenopausal hormone therapy offers no protection against heart attacks.
    Ginecologia y obstetricia de Mexico, 2002, Volume: 70

    Topics: Aged; Controlled Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Drug Combinations; Estrogens; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Gallbladder Diseases; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Myocardial Infarction; Placebos; Postmenopause; Progesterone Congeners; Progestins; Randomized Controlled Trials as Topic; Risk Factors; Thrombosis; Time Factors

2002
Physical, metabolic, and hormonal effects on men of long-term therapy with medroxyprogesterone acetate.
    Fertility and sterility, 1985, Volume: 43, Issue:1

    Topics: Adult; Blood Pressure; Body Weight; Follicle Stimulating Hormone; Gallbladder Diseases; Glucose Tolerance Test; Hematologic Tests; Humans; Injections, Intramuscular; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Paraphilic Disorders; Penis; Semen; Sperm Count; Sperm Motility; Testis; Testosterone; Time Factors

1985